Datavault AI Lands in Controversy as Shareholders Challenge Securities Misrepresentation
Datavault AI Faces Scrutiny Over Securities Class Action
In a striking turn of events, Datavault AI Inc. (NASDAQ: DVLT) is under fire from investors who claim the company misrepresented its financial prospects. Following bold announcements of substantial investments and lucrative partnerships, reality appears much bleaker, as highlighted by SueWallSt. This article delves into the contrasting narratives and implications for shareholders.
The Promised Future
In September 2025, Datavault AI touted a promising future, asserting a $150 million investment from Scilex Holding Company was on the horizon. This move was intended to fund a cutting-edge supercomputer and independent data exchanges, placing Datavault in a prime position within the tech landscape. Shortly after, the company announced a license agreement with Nature's Miracle, which included a non-refundable fee of $2 million plus a commission of 35% in royalties. Furthermore, the company spoke highly of a strategic partnership with Burke Products, eyeing revenues within the defense sector, supported by a budget exceeding $900 billion.
The Darker Reality
However, a short-seller report released on October 31, 2025, cast doubt on these optimistic assertions. The report indicated that Scilex, instead of having $150 million in investment capabilities, only had $4.1 million in liquid assets. Nature's Miracle, during its recent filing, showed a startling lack of funds, reporting merely $9,511. Additionally, evidence surfaced stating that Burke Products had consistently failed to secure significant contracts, with a maximum contract award of $4.5 million since 2002. This stark contrast between projected figures and actual financial standings raises serious concerns about the integrity of the company's communications to investors.
A Breakdown of Miscommunication
| Promised | Alleged Reality |
|---|---|
| ------- | --------- |
| Scilex investment of $150 million | Alleged cash of $4.1 million |
| Nature's Miracle license fee of $2 million | Alleged cash of $9,511 |
| Defense sector positioning tied to a $900 billion budget | Alleged Burke 2025 awards of approximately $3.1 million |
| Datavault Platform acquisition at $210 million | Minimal trading activity |
| Insider stock sale proceeds during Class Period: $73.8 million | N/A |
Investors' Response
The lawsuit, driven by claims from aggrieved shareholders, posits that Datavault AI grossly overstated the viability and value of its partnerships. This leads to a troubling narrative: investors purchased shares under inflated prices, only to incur significant losses when the truth was revealed.
Joseph E. Levi, Esq., representing the investors, stated, "Companies have a responsibility to disclose known risks correlating with their future performance projections. The gaps between promised values and actual resources are substantial and alarming."
Next Steps for Affected Investors
The court has set a deadline for October 5, 2026, for investors wishing to file as lead plaintiffs in the securities class action. Investors who purchased DVLT shares between September 4, 2024, and October 30, 2025, should review their brokerage statements to document their investments for potential restitution.
FAQs About the Lawsuit
1. What misstatements does the lawsuit allege?
The complaint outlines that Datavault AI made seriously misleading claims about partnerships' economic values and trading volumes on its platform—leading to a drastic stock price drop when these inaccuracies surfaced.
2. What is the stock price drop?
Following the report, DVLT shares fell by about 19.44%, equating to a loss of $0.49 per share, closing at $2.03.
3. Who is eligible for the lawsuit?
Investors who acquired DVLT stock within the specified date range and experienced financial losses may qualify to participate in this class action.
4. What actions should investors take?
Investors are urged to compile documentation that displays the purchase dates and quantities of shares, then contact SueWallSt for a complimentary case evaluation.
Conclusion
The unfolding situation with Datavault AI serves as a cautionary tale for investors. Missed projections and misleading communications can devastate shareholder confidence and market valuations. As the legal proceedings develop, it will be crucial for investors to stay informed and proactive in protecting their interests.
For more information on the case, interested shareholders should reach out to SueWallSt for guidance on how to proceed.
Contact:
Levi Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Phone: (888) SueWallSt
Disclaimer: Attorney Advertising. Past results do not guarantee similar outcomes.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.